DBVT
NASDAQ
$14.57
DBV Technologies (DBVT)
DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, France.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $40.79 (+179.96%)
Market Cap
$930M
Free Cash Flow Yield
-16.29%
Beta (5Y)
0.28
Price Chart
Valuation
Market Cap$930M
P/S153.33
P/B4.46
Profitability
Total Revenue (TTM)$5.74M
Gross Profit (TTM)$5.04M
EBITDA-$164M
Operating Margin-5311%
EPS-$4.49
Financial Health
Free Cash Flow Yield-16.29%
Growth & Risk
Revenue 5Y CAGR-9.59%
FCF 5Y CAGR-0.35%
Beta (5Y)0.28
Sharpe Ratio0.85